CD19 and CD4 counts were significantly lower in Group D than in Group A. These results suggest worse immune dysfunction in patients with low LDL-C levels, which has been recognized as an important factor in the occurrence and development of COVID-19 since the beginning of the epidemic (42). The gene discussed is CD19; the disease is COVID-19.